From: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49
Variable | N = 216 % | SF-36 Physical | SF-36 Mental | CARES-SF Global | CARES-SF Sexuality | CES-D |
---|---|---|---|---|---|---|
Mean (Standard Deviation) | ||||||
Scale average | 48.6 (11.5) | 46.8 (11.3) | 0.6 (0.5) | 1.4 (1.2) | 11.8 (10.6) | |
Tumor node and metastates stage | ||||||
0 | 13.0 | 52.2 (7.9) | 48.1 (11.2) | 0.4 (0.4) | 0.9 (1.1) | 10.3 (10.3) |
I | 29.2 | 48.1 (10.2) | 46.3 (10.4) | 0.6 (0.5) | 1.5 (1.1) | 12.5 (10.7) |
IIA & IIB | 29.6 | 48.2 (11.7) | 46.29 (11.3) | 0.7 (0.5) | 1.8 (1.4) | 12.2 (11.2) |
III & IV | 6.0 | 42.6 (15.0) | 44.6 (11.3) | 0.8 (0.6) | 1.8 (1.2) | 15.1 (11.9) |
Missing | 22.2 | 49.1 (13.3) | 47.8 (12.8) | 0.6 (0.4) | 1.2 (1.1) | 10.2 (9.6) |
Age at survey | ||||||
45–49 yrs | 26.1 | 49.7 (11.9) | 44.9 (12.5) | 0.7 (0.5) | 1.5 (1.2) | 13.6 (12.4) |
50–54 yrs | 51.2 | 48.0 (11.5) | 47.5 (10.8) | 0.6 (0.4) | 1.3 (1.2) | 10.9 (9.3) |
55–60 yrs | 22.8 | 48.7 (11.3) | 47.2 (11.1) | 0.6 (0.5) | 1.6 (1.3) | 11.8 (11.0) |
Breast cancer recurrence since diagnosis | ||||||
No | 84.7 | 48.7 (11.1) | 46.9 (11.5) | 0.6 (0.5) | 1.4 (1.2) | 11.6 (10.5) |
Yes | 15.3 | 48.5 (13.4) | 46.3 (10.6) | 0.7 (0.5) | 1.6 (1.3) | 12.7 (11.3) |
Presence of breast-related symptoms at survey | ||||||
No | 62.3 | 50.9 (9.4) | 48.2 (11.0) | 0.5 (0.4) | 1.3 (1.2) | 9.9 (9.1) |
Yes | 37.7 | 44.9 (13.5) | 44.2 (11.3) | 0.8 (0.6) | 1.7 (1.3) | 15.1 (12.1) |
Type of breast symptom among women with symptoms at survey (not mutually exclusive) | ||||||
Pain | 19.4 | 44.2 (12.6) | 41.2 (10.4) | 0.9 (0.6) | 2.1 (1.3) | 17.4 (12.2) |
Swelling | 10.3 | 44.8 (14.7) | 47.0 (9.1) | 0.7 (0.6) | 1.7 (1.3) | 12.4 (11.5) |
Numbness | 3.3 | 55.2 (7.2) | 45.4 (13.7) | 0.5 (0.3) | 1.2 (0.8) | 13.4 (17.0) |
Other | 8.4 | 43.0 (14.1) | 45.4 (11.1) | 0.6 (0.4) | 1.1 (1.5) | 14.2 (8.9) |
Type of surgery (mutually exclusive) | ||||||
Breast conserving therapy | 45.8 | 50.6 (10.0) | 46.0 (12.1) | 0.6 (0.5) | 1.5 (1.3) | 12.3 (11.9) |
Mastectomy | 54.2 | 47.0 (12.3) | 47.4 (10.7) | 0.6 (0.5) | 1.4 (1.1) | 11.3 (9.4) |
Type of therapy (not mutually exclusive) | ||||||
None | 15.8 | 51.2 (10.6) | 46.6 (12.6) | 0.4 (0.3) | 0.7 (0.7) | 11.7 (9.9) |
Radiation | 62.8 | 49.5 (10.8) | 46.5 (11.4) | 0.6 (0.5) | 1.6 (1.3) | 12.1 (11.3) |
Chemotherapy | 54.9 | 46.8 (12.6) | 46.1 (11.3) | 0.7 (0.5) | 1.8 (1.2) | 12.4 (10.7) |
Hormonal therapy | 37.2 | 46.9 (11.8) | 45.5 (11.3) | 0.6 (0.5) | 1.7 (1.1) | 12.8 (11.5) |
Menopausal status | ||||||
Pre or peri-menopausal | 16.4 | 49.8 (10.6) | 50.6 (9.4) | 0.6 (0.6) | 1.0 (1.3) | 9.1 (10.5) |
Postmenopausal | 83.6 | 48.3 (11.6) | 46.1 (11.5) | 0.6 (0.5) | 1.5 (1.2) | 12.3 (10.6) |
Health behaviors | ||||||
Current smoker | 9.3 | 43.8 (15.2) | 45.3 (9.7) | 0.8 (0.6) | 1.8 (1.6) | 15.2 (11.8) |
Non-smoker | 90.7 | 49.1 (11.0) | 46.9 (11.5) | 0.6 (0.5) | 1.4 (1.2) | 11.4 (10.4) |
Last Pap smear < 4 years ago | 90.0 | 49.3 (11.3) | 47.2 (11.0) | 0.6 (0.5) | 1.4 (1.2) | 11.3 (10.3) |
Last Pap smear ≥4 years ago | 10.0 | 44.0 (11.6) | 45.6 (11.2) | 0.7 (0.5) | 1.7 (1.1) | 13.8 (11.5) |
Last mammogram <2 years ago | 89.1 | 49.6 (10.5) | 46.5 (11.0) | 0.6 (0.5) | 1.4 (1.2) | 11.6 (10.2) |
Last mammogram ≥2 years ago | 10.9 | 40.8 (15.6) | 49.8 (11.7) | 0.8 (0.6) | 1.6 (1.3) | 13.0 (12.4) |
Education | ||||||
≤ High school | 21.7 | 46.6 (13.0) | 47.0 (11.4) | 0.7 (0.5) | 1.6 (1.2) | 12.0 (9.2) |
Some college/technical school | 36.8 | 47.3 (11.9) | 45.5 (12.2) | 0.7 (0.5) | 1.5 (1.3) | 14.6 (12.2) |
≥ College graduate | 41.5 | 51.1 (9.7) | 48.1 (9.9) | 0.5 (0.4) | 1.2 (1.1) | 8.9 (8.6) |
Ethnicity | ||||||
Non-Caucasian | 7.6 | 47.4 (13.6) | 49.5 (13.2) | 0.7 (0.8) | 1.4 (1.4) | 12.8 (15.5) |
Caucasian | 92.4 | 48.9 (11.3) | 46.7 (11.0) | 0.6 (0.5) | 1.4 (1.2) | 11.5 (10.0) |
Employment status at survey (N = 189) | ||||||
Employed | 76.2 | 49.7 (11.0) | 46.9 (11.3) | 0.6 (0.5) | 1.5 (1.2) | 11.2 (10.2) |
Unemployed | 23.8 | 46.3 (13.2) | 46.7 (12.6) | 0.7 (0.6) | 1.5 (1.2) | 13.1 (12.2) |
Income (N = 198) | ||||||
<$35,000 | 23.1 | 43.4 (14.4) | 45.1 (11.7) | 0.8 (0.6) | 1.7 (1.2) | 14.4 (11.2) |
$35,001–75,000 | 43.1 | 49.9 (10.2) | 45.8 (11.3) | 0.6 (0.5) | 1.4 (1.2) | 11.6 (10.2) |
>$75,000 | 33.9 | 51.6 (9.2) | 49.3 (10.5) | 0.5 (0.4) | 1.3 (1.2) | 9.8 (10.2) |
Chronic disease score at survey | ||||||
0 | 53.2 | 50.3 (10.6) | 47.5 (10.9) | 0.5 (0.4) | 1.4 (1.3) | 11.2 (10.1) |
1 to 3 | 25.9 | 50.3 (8.7) | 47.0 (12.8) | 0.6 (0.5) | 1.5 (1.1) | 11.3 (12.1) |
≥4 | 20.8 | 42.2 (14.3) | 44.8 (10.4) | 0.7 (0.5) | 1.5 (1.2) | 13.9 (9.7) |